Treace Medical Concepts Q3 2024 Earnings Report $6.96 +0.06 (+0.87%) (As of 12/20/2024 05:16 PM ET) Earnings HistoryForecast Treace Medical Concepts EPS ResultsActual EPS-$0.25Consensus EPS -$0.27Beat/MissBeat by +$0.02One Year Ago EPS-$0.28Treace Medical Concepts Revenue ResultsActual Revenue$45.09 millionExpected Revenue$43.48 millionBeat/MissBeat by +$1.61 millionYoY Revenue Growth+10.60%Treace Medical Concepts Announcement DetailsQuarterQ3 2024Date11/5/2024TimeAfter Market ClosesConference Call ResourcesConference CallConference Call TranscriptTMCI Earnings History Cackling Kamala hates this company (Ad)Do you want to see one of the most exciting election trades of all time? A trade that could help America become 100% energy independent… Reduce energy costs to virtually zero… And hand investors what could be a stunning return in just a few years’ time? It all has to do with a little known company that is helping to kick off the next great American energy revolution. Before that happens, you need to see the details here. Treace Medical Concepts Earnings HeadlinesTreace Medical Concepts (NASDAQ:TMCI) Price Target Raised to $8.40 at Truist FinancialDecember 20 at 3:23 AM | americanbankingnews.comJPMorgan Chase & Co. Reaffirms "Neutral" Rating for Treace Medical Concepts (NASDAQ:TMCI)December 19 at 1:58 AM | americanbankingnews.comCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more than $9 trillion. That’s nearly 10 times more money than the market caps of Tesla… SpaceX… PayPal… Neuralink… and X… COMBINED.December 21, 2024 | Brownstone Research (Ad)Deep Dive Into Treace Medical Concepts Stock: Analyst Perspectives (4 Ratings)December 18 at 4:42 PM | benzinga.comTreace Medical assumed with a Neutral at JPMorganDecember 18 at 6:42 AM | markets.businessinsider.comTreace Announces First Surgical Cases Utilizing the SpeedPlate™ MicroQuad™ ImplantDecember 16, 2024 | globenewswire.comSee More Treace Medical Concepts Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Treace Medical Concepts? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Treace Medical Concepts and other key companies, straight to your email. Email Address About Treace Medical ConceptsTreace Medical Concepts (NASDAQ:TMCI), a medical technology company, designs, manufactures, and markets medical devices in the United States. The company offers Lapiplasty 3D bunion correction system that combines instruments, implants, and surgical methods designed to surgically correct three planes of the bunion deformity. It also provides Lapiplasty mini-incision system designed to allow the Lapiplasty procedure to be performed through a 3.5cm incision. In addition, the company offers Adductoplasty system designed for reproducible realignment, stabilization, and fusion of the midfoot. Treace Medical Concepts, Inc. was founded in 2013 and is headquartered in Ponte Vedra, Florida.View Treace Medical Concepts ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles History Hints at a Rebound for Toll Brothers After EarningsAlibaba Stock: Why Earnings Make It a Buy Despite the Recent DipMercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip?Roblox Stock Soars 22% After Q3 Earnings – A Turning Point Ahead?Apple Earnings - When Really Good Just Isn’t Good Enough Roblox Stock Set for More Gains After Strong Earnings ReportAmazon: Why Analysts Think It's a Solid Buy Ahead of Earnings Upcoming Earnings Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
